Table 2.
Favoring effect | Impeding effect |
---|---|
High prevalence of KS in malarial areas with widespread use of quinine and its derivates18 | Quinolines are potential anticancer agents alone or in combination with other antineoplastic drugs: inhibition of autophagy and apoptosis92., 93., 94. |
Low prevalence of KS in areas where malaria is rare and quinine derivates are rarely used19 | Lysosomotropic effects of quinolines inhibit pH-dependent steps of viral entry and replication99., 100., 101. |
Use of quinine to “cut” heroin in drug addicts affected by AIDS-KS85 | Quinolines inhibit angiogenesis, hallmark of KS pathogenesis95 |
Well-known immunosuppressive properties of quinine and its derivatives, largely used in the treatment of autoimmune diseases (SLE, DLE, rheumatoid arthritis)82 | Quinolines inhibit production of pro-inflammatory cytokines, involved in HHV-8 lytic cycle reactivation96 |
Antimalarials indirectly encourage the onset of KS, through their inhibitory effect on TNF-α expression103 | Antimalarials indirectly prevent the onset of KS, through their inhibitory effect on TNF-α expression102 |
Chloroquine can reduce the antibody response to primary immunization83 | |
ACE inhibitor intake can induce KS86., 87. | ACE inhibitor intake can protect from KS104 |
ACE, angiotensin-converting enzyme; DLE, discoid lupus erythematosus; HHV, human herpesvirus; KS, Kaposi’s sarcoma; SLE, Systemic lupus erythematosus; TNF, tumor necrosis factor.